Bismuth subsalicylate (Pepto-Bismol)

bismuth subsalicylate · Church & Dwight Co., Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bismuth subsalicylate (Pepto-Bismol), covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults [Phase 1]